You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombocythemia Myelofibrosis

Showing 26 - 50 of 412
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

Recruiting
  • Myelofibrosis
  • +5 more
  • Birmingham, Alabama
  • +27 more
Oct 17, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Scottsdale, Arizona
  • +21 more
Jan 18, 2021

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
Jun 5, 2021

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

Terminated
  • Essential Thrombocythemia
  • +2 more
  • Arsenic Trioxide
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

Completed
Has Results
  • Chronic Phase Myelofibrosis
  • +3 more
  • Boston, Massachusetts
  • +2 more
May 27, 2021

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

Completed
Has Results
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Phoenix, Arizona
  • +12 more
Jan 12, 2021

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +28 more
May 5, 2022

Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 7, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 19, 2022

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

Terminated
Has Results
  • Myelofibrosis
  • Stanford, California
  • +1 more
Aug 31, 2020

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Jul 9, 2021

Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

Recruiting
  • Myelofibrosis Transformation in Essential Thrombocythemia
  • +2 more
  • Elotuzumab
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2021

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

Enrolling by invitation
  • Thrombocythemia, Essential
  • Primary Myelofibrosis
  • Miami, Florida
  • +18 more
Jan 30, 2023

Study (MOST)

Completed
  • MPN (Myeloproliferative Neoplasms)
    • Huntsville, Alabama
    • +115 more
    May 11, 2022